Soteropoulos Paula — SEC Form 4 filings
SEC reporting owner CIK 1692444. 9 Form 4 filings on record with FilingPulse; latest filed 2026-05-22.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-05-17 to 2026-05-22. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 4 legs across 4 filings — 31,012 shares, $2,264,305 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 11.
- Largest priced transaction: sale of 27,594 shares @ $78.05 ($2,153,712) in Dianthus Therapeutics, Inc. /DE/, filed 2026-03-26.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | Director | 6 | — | 3 legs · 28,792 sh · $2,252,894 | 9 |
| uniQure N.V. (QURE) | Director | 1 | — | 1 leg · 2,220 sh · $11,411 | — |
| Rallybio Corp (RLYB) | Director | 2 | — | — | 2 |
Form 4 filings — Soteropoulos Paula
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-05-22 | 4 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Grant/award (A): 6,090 (derivative) @ $0 | EDGAR |
| 2026-05-11 | 4 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Option exercise (M): 599 @ $8.44 · Sale (S): 599 @ $85.47 · Option exercise (M): 599 (derivative) @ $0 | EDGAR |
| 2026-04-01 | 4 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Option exercise (M): 599 @ $8.44 · Sale (S): 599 @ $80.11 · Option exercise (M): 599 (derivative) @ $0 | EDGAR |
| 2026-03-26 | 4 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Option exercise (M): 27,594 @ $8.44 · Sale (S): 27,594 @ $78.05 · Option exercise (M): 27,594 (derivative) @ $0 | EDGAR |
| 2025-05-22 | 4 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2025-05-15 | 4 | Rallybio Corp (RLYB) | Grant/award (A): 28,500 (derivative) @ $0 | EDGAR |
| 2024-06-17 | 4 | uniQure N.V. (QURE) | Sale (S): 2,220 @ $5.14 | EDGAR |
| 2024-05-28 | 4 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | Grant/award (A): 11,000 (derivative) @ $0 | EDGAR |
| 2024-05-17 | 4 | Rallybio Corp (RLYB) | Grant/award (A): 16,500 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1692444 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →